 | • レポートコード：QYR2104Z4356 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、OTC医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クラスAOTC医薬品、クラスBOTC医薬品）、用途別市場規模（病院、診療所、家庭）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・OTC医薬品の市場動向 ・企業の競争状況、市場シェア ・OTC医薬品の種類別市場規模（クラスAOTC医薬品、クラスBOTC医薬品） ・OTC医薬品の用途別市場規模（病院、診療所、家庭） ・OTC医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・OTC医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・OTC医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・OTC医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・OTC医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer HealthCare、GlaxoSmithKline(GSK)、Johnson&Johnson、Pfizer、Sanofi、AstraZeneca、BioGaia、Bristol Myers Squibb、Bukwang Pharmaceutica、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite） ・結論 |
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
Market Analysis and Insights: Global OTC Drug Market
The global OTC Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Drug market.
Global OTC Drug Scope and Market Size
OTC Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Class A OTC Drug
Class B OTC Drug
Segment by Application
Hospital
Clinic
Household
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Class A OTC Drug
1.2.3 Class B OTC Drug
1.3 Market by Application
1.3.1 Global OTC Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Drug Market Perspective (2016-2027)
2.2 OTC Drug Growth Trends by Regions
2.2.1 OTC Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 OTC Drug Historic Market Share by Regions (2016-2021)
2.2.3 OTC Drug Forecasted Market Size by Regions (2022-2027)
2.3 OTC Drug Industry Dynamic
2.3.1 OTC Drug Market Trends
2.3.2 OTC Drug Market Drivers
2.3.3 OTC Drug Market Challenges
2.3.4 OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Drug Players by Revenue
3.1.1 Global Top OTC Drug Players by Revenue (2016-2021)
3.1.2 Global OTC Drug Revenue Market Share by Players (2016-2021)
3.2 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by OTC Drug Revenue
3.4 Global OTC Drug Market Concentration Ratio
3.4.1 Global OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2020
3.5 OTC Drug Key Players Head office and Area Served
3.6 Key Players OTC Drug Product Solution and Service
3.7 Date of Enter into OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Drug Breakdown Data by Type
4.1 Global OTC Drug Historic Market Size by Type (2016-2021)
4.2 Global OTC Drug Forecasted Market Size by Type (2022-2027)
5 OTC Drug Breakdown Data by Application
5.1 Global OTC Drug Historic Market Size by Application (2016-2021)
5.2 Global OTC Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America OTC Drug Market Size (2016-2027)
6.2 North America OTC Drug Market Size by Type
6.2.1 North America OTC Drug Market Size by Type (2016-2021)
6.2.2 North America OTC Drug Market Size by Type (2022-2027)
6.2.3 North America OTC Drug Market Size by Type (2016-2027)
6.3 North America OTC Drug Market Size by Application
6.3.1 North America OTC Drug Market Size by Application (2016-2021)
6.3.2 North America OTC Drug Market Size by Application (2022-2027)
6.3.3 North America OTC Drug Market Size by Application (2016-2027)
6.4 North America OTC Drug Market Size by Country
6.4.1 North America OTC Drug Market Size by Country (2016-2021)
6.4.2 North America OTC Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe OTC Drug Market Size (2016-2027)
7.2 Europe OTC Drug Market Size by Type
7.2.1 Europe OTC Drug Market Size by Type (2016-2021)
7.2.2 Europe OTC Drug Market Size by Type (2022-2027)
7.2.3 Europe OTC Drug Market Size by Type (2016-2027)
7.3 Europe OTC Drug Market Size by Application
7.3.1 Europe OTC Drug Market Size by Application (2016-2021)
7.3.2 Europe OTC Drug Market Size by Application (2022-2027)
7.3.3 Europe OTC Drug Market Size by Application (2016-2027)
7.4 Europe OTC Drug Market Size by Country
7.4.1 Europe OTC Drug Market Size by Country (2016-2021)
7.4.2 Europe OTC Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific OTC Drug Market Size (2016-2027)
8.2 Asia-Pacific OTC Drug Market Size by Type
8.2.1 Asia-Pacific OTC Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific OTC Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific OTC Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific OTC Drug Market Size by Application
8.3.1 Asia-Pacific OTC Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific OTC Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific OTC Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific OTC Drug Market Size by Region
8.4.1 Asia-Pacific OTC Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific OTC Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Drug Market Size (2016-2027)
9.2 Latin America OTC Drug Market Size by Type
9.2.1 Latin America OTC Drug Market Size by Type (2016-2021)
9.2.2 Latin America OTC Drug Market Size by Type (2022-2027)
9.2.3 Latin America OTC Drug Market Size by Type (2016-2027)
9.3 Latin America OTC Drug Market Size by Application
9.3.1 Latin America OTC Drug Market Size by Application (2016-2021)
9.3.2 Latin America OTC Drug Market Size by Application (2022-2027)
9.3.3 Latin America OTC Drug Market Size by Application (2016-2027)
9.4 Latin America OTC Drug Market Size by Country
9.4.1 Latin America OTC Drug Market Size by Country (2016-2021)
9.4.2 Latin America OTC Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Drug Market Size (2016-2027)
10.2 Middle East & Africa OTC Drug Market Size by Type
10.2.1 Middle East & Africa OTC Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa OTC Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa OTC Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa OTC Drug Market Size by Application
10.3.1 Middle East & Africa OTC Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa OTC Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa OTC Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa OTC Drug Market Size by Country
10.4.1 Middle East & Africa OTC Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa OTC Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare OTC Drug Introduction
11.1.4 Bayer HealthCare Revenue in OTC Drug Business (2016-2021)
11.1.5 Bayer HealthCare Recent Development
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Details
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) OTC Drug Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2016-2021)
11.2.5 GlaxoSmithKline(GSK) Recent Development
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Details
11.3.2 Johnson&Johnson Business Overview
11.3.3 Johnson&Johnson OTC Drug Introduction
11.3.4 Johnson&Johnson Revenue in OTC Drug Business (2016-2021)
11.3.5 Johnson&Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer OTC Drug Introduction
11.4.4 Pfizer Revenue in OTC Drug Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi OTC Drug Introduction
11.5.4 Sanofi Revenue in OTC Drug Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca OTC Drug Introduction
11.6.4 AstraZeneca Revenue in OTC Drug Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 BioGaia
11.7.1 BioGaia Company Details
11.7.2 BioGaia Business Overview
11.7.3 BioGaia OTC Drug Introduction
11.7.4 BioGaia Revenue in OTC Drug Business (2016-2021)
11.7.5 BioGaia Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb OTC Drug Introduction
11.8.4 Bristol Myers Squibb Revenue in OTC Drug Business (2016-2021)
11.8.5 Bristol Myers Squibb Recent Development
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Details
11.9.2 Bukwang Pharmaceutica Business Overview
11.9.3 Bukwang Pharmaceutica OTC Drug Introduction
11.9.4 Bukwang Pharmaceutica Revenue in OTC Drug Business (2016-2021)
11.9.5 Bukwang Pharmaceutica Recent Development
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Details
11.10.2 Chr. Hansen Business Overview
11.10.3 Chr. Hansen OTC Drug Introduction
11.10.4 Chr. Hansen Revenue in OTC Drug Business (2016-2021)
11.10.5 Chr. Hansen Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla OTC Drug Introduction
11.11.4 Cipla Revenue in OTC Drug Business (2016-2021)
11.11.5 Cipla Recent Development
11.12 CoLucid
11.12.1 CoLucid Company Details
11.12.2 CoLucid Business Overview
11.12.3 CoLucid OTC Drug Introduction
11.12.4 CoLucid Revenue in OTC Drug Business (2016-2021)
11.12.5 CoLucid Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo OTC Drug Introduction
11.13.4 Daiichi Sankyo Revenue in OTC Drug Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Friggs
11.14.1 Friggs Company Details
11.14.2 Friggs Business Overview
11.14.3 Friggs OTC Drug Introduction
11.14.4 Friggs Revenue in OTC Drug Business (2016-2021)
11.14.5 Friggs Recent Development
11.15 DSM
11.15.1 DSM Company Details
11.15.2 DSM Business Overview
11.15.3 DSM OTC Drug Introduction
11.15.4 DSM Revenue in OTC Drug Business (2016-2021)
11.15.5 DSM Recent Development
11.16 Eisai
11.16.1 Eisai Company Details
11.16.2 Eisai Business Overview
11.16.3 Eisai OTC Drug Introduction
11.16.4 Eisai Revenue in OTC Drug Business (2016-2021)
11.16.5 Eisai Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly OTC Drug Introduction
11.17.4 Eli Lilly Revenue in OTC Drug Business (2016-2021)
11.17.5 Eli Lilly Recent Development
11.18 Herbalife
11.18.1 Herbalife Company Details
11.18.2 Herbalife Business Overview
11.18.3 Herbalife OTC Drug Introduction
11.18.4 Herbalife Revenue in OTC Drug Business (2016-2021)
11.18.5 Herbalife Recent Development
11.18 Euradite
.1 Euradite Company Details
.2 Euradite Business Overview
.3 Euradite OTC Drug Introduction
.4 Euradite Revenue in OTC Drug Business (2016-2021)
.5 Euradite Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global OTC Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Class A OTC Drug
Table 3. Key Players of Class B OTC Drug
Table 4. Global OTC Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global OTC Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global OTC Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global OTC Drug Market Share by Regions (2016-2021)
Table 8. Global OTC Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global OTC Drug Market Share by Regions (2022-2027)
Table 10. OTC Drug Market Trends
Table 11. OTC Drug Market Drivers
Table 12. OTC Drug Market Challenges
Table 13. OTC Drug Market Restraints
Table 14. Global OTC Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global OTC Drug Market Share by Players (2016-2021)
Table 16. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2020)
Table 17. Ranking of Global Top OTC Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by OTC Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players OTC Drug Product Solution and Service
Table 21. Date of Enter into OTC Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global OTC Drug Revenue Market Share by Type (2016-2021)
Table 25. Global OTC Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global OTC Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global OTC Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global OTC Drug Revenue Market Share by Application (2016-2021)
Table 29. Global OTC Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global OTC Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific OTC Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific OTC Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare OTC Drug Product
Table 64. Bayer HealthCare Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 65. Bayer HealthCare Recent Development
Table 66. GlaxoSmithKline(GSK) Company Details
Table 67. GlaxoSmithKline(GSK) Business Overview
Table 68. GlaxoSmithKline(GSK) OTC Drug Product
Table 69. GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline(GSK) Recent Development
Table 71. Johnson&Johnson Company Details
Table 72. Johnson&Johnson Business Overview
Table 73. Johnson&Johnson OTC Drug Product
Table 74. Johnson&Johnson Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 75. Johnson&Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer OTC Drug Product
Table 79. Pfizer Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi OTC Drug Product
Table 84. Sanofi Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca OTC Drug Product
Table 89. AstraZeneca Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. BioGaia Company Details
Table 92. BioGaia Business Overview
Table 93. BioGaia OTC Drug Product
Table 94. BioGaia Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 95. BioGaia Recent Development
Table 96. Bristol Myers Squibb Company Details
Table 97. Bristol Myers Squibb Business Overview
Table 98. Bristol Myers Squibb Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 99. Bristol Myers Squibb Recent Development
Table 100. Bukwang Pharmaceutica Company Details
Table 101. Bukwang Pharmaceutica Business Overview
Table 102. Bukwang Pharmaceutica OTC Drug Product
Table 103. Bukwang Pharmaceutica Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 104. Bukwang Pharmaceutica Recent Development
Table 105. Chr. Hansen Company Details
Table 106. Chr. Hansen Business Overview
Table 107. Chr. Hansen OTC Drug Product
Table 108. Chr. Hansen Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 109. Chr. Hansen Recent Development
Table 110. Cipla Company Details
Table 111. Cipla Business Overview
Table 112. Cipla OTC Drug Product
Table 113. Cipla Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 114. Cipla Recent Development
Table 115. CoLucid Company Details
Table 116. CoLucid Business Overview
Table 117. CoLucid OTC Drug Product
Table 118. CoLucid Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 119. CoLucid Recent Development
Table 120. Daiichi Sankyo Company Details
Table 121. Daiichi Sankyo Business Overview
Table 122. Daiichi Sankyo OTC Drug Product
Table 123. Daiichi Sankyo Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 124. Daiichi Sankyo Recent Development
Table 125. Friggs Company Details
Table 126. Friggs Business Overview
Table 127. Friggs OTC Drug Product
Table 128. Friggs Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 129. Friggs Recent Development
Table 130. DSM Company Details
Table 131. DSM Business Overview
Table 132. DSM OTC Drug Product
Table 133. DSM Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 134. DSM Recent Development
Table 135. Eisai Company Details
Table 136. Eisai Business Overview
Table 137. Eisai OTC Drug Product
Table 138. Eisai Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 139. Eisai Recent Development
Table 140. Eli Lilly Company Details
Table 141. Eli Lilly Business Overview
Table 142. Eli Lilly OTC Drug Product
Table 143. Eli Lilly Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 144. Eli Lilly Recent Development
Table 145. Herbalife Company Details
Table 146. Herbalife Business Overview
Table 147. Herbalife OTC Drug Product
Table 148. Herbalife Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 149. Herbalife Recent Development
Table 150. Euradite Company Details
Table 151. Euradite Business Overview
Table 152. Euradite OTC Drug Product
Table 153. Euradite Revenue in OTC Drug Business (2016-2021) & (US$ Million)
Table 154. Euradite Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug Market Share by Type: 2020 VS 2027
Figure 2. Class A OTC Drug Features
Figure 3. Class B OTC Drug Features
Figure 4. Global OTC Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Household Case Studies
Figure 8. OTC Drug Report Years Considered
Figure 9. Global OTC Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global OTC Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global OTC Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global OTC Drug Market Share by Regions (2022-2027)
Figure 13. Global OTC Drug Market Share by Players in 2020
Figure 14. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2020
Figure 16. Global OTC Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global OTC Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America OTC Drug Market Share by Type (2016-2027)
Figure 20. North America OTC Drug Market Share by Application (2016-2027)
Figure 21. North America OTC Drug Market Share by Country (2016-2027)
Figure 22. United States OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe OTC Drug Market Share by Type (2016-2027)
Figure 26. Europe OTC Drug Market Share by Application (2016-2027)
Figure 27. Europe OTC Drug Market Share by Country (2016-2027)
Figure 28. Germany OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific OTC Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific OTC Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific OTC Drug Market Share by Region (2016-2027)
Figure 38. China OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America OTC Drug Market Share by Type (2016-2027)
Figure 46. Latin America OTC Drug Market Share by Application (2016-2027)
Figure 47. Latin America OTC Drug Market Share by Country (2016-2027)
Figure 48. Mexico OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa OTC Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa OTC Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa OTC Drug Market Share by Country (2016-2027)
Figure 54. Turkey OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bayer HealthCare Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 58. GlaxoSmithKline(GSK) Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 59. Johnson&Johnson Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 63. BioGaia Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 64. Bristol Myers Squibb Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 65. Bukwang Pharmaceutica Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 66. Chr. Hansen Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 67. Cipla Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 68. CoLucid Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 69. Daiichi Sankyo Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 70. Friggs Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 71. DSM Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 72. Eisai Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 74. Herbalife Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 75. Euradite Revenue Growth Rate in OTC Drug Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のOTC医薬品市場規模・現状・予測（2021年-2027年） Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions. Market Analysis and Insight…- 世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の薬物乱用検査サービス市場規模・現状・予測（2021年-2027年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年） Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositione…